GHRH analog (FDA) · visceral fat
The ReferenceBenefits, protocols and preparationOpen the reference →Tesamorelin is a stabilized GHRH analog (44 aa) — the only growth hormone secretagogue approved by the FDA (Egrifta). It stimulates your own GH in a pulsatile way, preserving natural IGF-1 feedback.
Its FDA-approved flagship use: reduces visceral abdominal fat (−15 to −18% in trials) — the fat that wraps around your organs.
Raises GH and IGF-1 pulsatilely, not flat. Preserves IGF-1 feedback, unlike exogenous growth hormone.
−37% liver fat in 12 months (Lancet HIV 2019) and a modest lean-mass gain.
Better executive function in 152 older adults after 20 weeks (Arch Neurol 2012).

More muscle, strength & composition
TesaFit+TesamorelinAdds lean mass · Raises GH and IGF-1 physiologically
+ EnergyDriveMOTS-c+ Adds: Preserves and protects muscle
+ BioGrowCJC-1295 + IpamorelinReinforces: Adds lean mass
+ AminoLean5-Amino-1MQ+ Adds: Regenerates muscle after injury
TesaFit+ + BioGrowTesamorelin + CJC-1295 + IpamorelinBioGrow (CJC-1295 + Ipamorelin) reinforces: Adds lean mass
TesaFit+ + EnergyDriveTesamorelin + MOTS-cEnergyDrive (MOTS-c) adds: Preserves and protects muscle
TesaFit+ + AminoLeanTesamorelin + 5-Amino-1MQAminoLean (5-Amino-1MQ) adds: Preserves and protects muscleTesamorelin is a stabilized synthetic analog of GHRH (growth hormone–releasing hormone, 44 amino acids) and is the only GHRH analog FDA-approved as a treatment (brand Egrifta; its WR version in 2025). Instead of injecting growth hormone directly, it asks your own pituitary to release it — pulsatilely and preserving natural IGF-1 feedback.
SuperBio Labs Tesamorelin is supplied as lyophilized powder with verified HPLC ≥99% purity. Each lot ships with an independent Certificate of Analysis confirming identity by LC-MS, peptide content (98–102%), and endotoxin levels (<1.0 EU/mg).
Its flagship lane, with high evidence, is reducing visceral abdominal fat: −15 to −18% in 26 weeks across two phase III trials with 806 people. A 2026 meta-analysis confirms it and adds less trunk fat and lower triglycerides. In fatty liver it cut liver fat by 37% over 12 months and slowed fibrosis progression (Lancet HIV 2019; confirmed in 2024). In older adults it improved executive function after 20 weeks (Arch Neurol 2012). The lean-mass gain is modest: this is not a muscle-building peptide. Two honest notes: most evidence comes from people with HIV and older adults, and visceral fat returns within a few months of stopping.
Within our catalog, Tesamorelin holds the GH-axis slot: it gains credibility (FDA) and a lane of its own (visceral fat), but it does not build muscle nor provide the ghrelin/sleep arm of an Ipamorelin.
Informed professional research use only.
Each order includes everything needed to use the full vial. No separate purchases required.
This product meets all five — your batch COA ships with the kit.
The official protocol included in the kit. If you have pre-diabetes, diabetes, or raised IGF-1, consult your physician before starting.
The fat around your organs · −15 to −18% in 26 weeks in phase III.
−37% liver fat in 12 months (HIV) · no published results outside HIV yet.
Raises GH and IGF-1 with your own pulses, no exogenous GH · monitor with labs.
Better executive function after 20 weeks in 152 older adults.
Triglycerides fell along with visceral fat in phase III.
When stopped, visceral fat returns within months · the effect lasts while you keep going.
Generally well tolerated, but with clear monitoring. This is not a harmless peptide: it has real contraindications.
It raises IGF-1 (monitor with labs) and can raise glucose/insulin — caution in pre-diabetes and diabetes. It may cause fluid retention and arthralgia (joint pain). Contraindicated in active cancer, pituitary disease, and pregnancy. For athletes: it is on the WADA list (S2.2.4). Never combine it with CJC-1295 (both are GHRH).
| CAS number | 218949-48-5 |
| Molecular weight | 5135.9 Da |
| Class | GHRH analog (44 aa) |
| Purity (HPLC) | ≥99% |
| Format | Lyophilized powder |
| Quantity | 20 mg per vial |
| Endotoxins | <1.0 EU/mg |
| Storage | −20 °C, protected from light |
| Use | Use under professional judgment |